The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective.
This review will highlight key breakthroughs, clinical integration, limitations, and future directions related to immunotherapy for lung cancer.
We have 2 of 108 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
This review will highlight key breakthroughs, clinical integration, limitations, and future directions related to immunotherapy for lung cancer.
This review discusses recent advances in EGFR-targeted therapies within the molecular landscape of classical and uncommon EGFR mutations, focusing on frontline intensification strategies in metastatic disease—specifically TKI combinations with chemotherapy or bispecific antibodies or bispecific antibodies—and emerging...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.